Understanding policies and principles regarding commercialization

Commercialization

The Commercialization Strategy articulates clear policies on the creation, use and protection of any IP to maximize benefits to Canada.

This strategy will allow the DHDP to efficiently identify and mobilize key industry partners to perform this productization stage, either within DHDP members (industry, start-ups, SMEs) or outside of the DHDP as necessary. It will also include a process to evaluate eligible projects potential for commercialization, helping members navigate IP strategies, and safeguarding against commercialization of patient data. The Commercialization Strategy is intended to ensure that Canada is a top destination for businesses to invest, grow and create jobs and prosperity for Canadians, and to spur innovation for a better Canada.

The strategy is intended to balance proprietary and open source strategies, while fostering ownership and use of the eligible projects IP in Canada. The policy will further demonstrate value creation/retention, accessibility, and transparency by delineating appropriate licensing and royalty structures for different types of entities and project types (e.g., research projects vs. commercialization projects).

Frequently Asked Questions about Commercialization

Who owns the IP on models developed using federated data?

The Commercialization Committee is tasked with developing a strategy that articulates clear policies on the creation, use and protection of any IP to maximize benefits to Canada. The policy shall further demonstrate value creation/retention, accessibility, and transparency by delineating appropriate licensing and royalty structures for different types of entities and project types (e.g., research projects vs. commercialization projects). We are relying on current mechanisms in place at each institution that have proven effective to manage licenses, royalties and commercialization, including but not limited to approvals by ethics review boards and offices of technology transfers. Underlying IP agreements will need to be in place before projects are funded. One such mechanism in place is the Imagia’s EVIDENS agreements organizing all aspects of data use, IP management and commercialization.